Patent · US Active

Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production

US9522932B2 · kind B2 · utility

0Cited by

5References

14Claims

0Family size

Assignee

K.U. Leuven Research & Development · BE

Inventors

Piet Herdewijn · Wezemaal, BE
Christophe Pannecouque · Heverlee, BE
Tongfei Wu · Leuven, BE
Erik De Clercq · Lovenjoel, BE

Key dates

Filing date	Sep 28, 2015
Grant date	Dec 20, 2016
Priority date	—
Expiry date	Sep 28, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/16
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention is directed to a process for the preparation of substituted threonolactone and substituted threose compounds which are intermediates in the synthesis of phosphonate nucleosides being useful antiviral agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.